Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings

[1]  Paul C. Lambert,et al.  Capturing simple and complex time-dependent effects using flexible parametric survival models: A simulation study , 2019, Commun. Stat. Simul. Comput..

[2]  J. Campbell,et al.  Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis , 2020, BMJ.

[3]  H. Zar,et al.  The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis , 2020, The Lancet.

[4]  C. Jackson,et al.  Evaluation of QuantiFERON-TB Gold Plus for Predicting Incident Tuberculosis among Recent Contacts: A Prospective Cohort Study , 2020, Annals of the American Thoracic Society.

[5]  Gibril J. Njie,et al.  Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020 , 2020, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[6]  Ruoran Li,et al.  Two Clinical Prediction Tools to Improve Tuberculosis Contact Investigation , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  Eric S. Ramos,et al.  A household-level score to predict the risk of tuberculosis among contacts of patients with tuberculosis: a derivation and external validation prospective cohort study , 2020, The Lancet. Infectious diseases.

[8]  J. Deeks,et al.  Quantitative Interferon Gamma Release Assay and Tuberculin Skin Test Results to Predict Incident Tuberculosis: A Prospective Cohort Study. , 2019, American journal of respiratory and critical care medicine.

[9]  Andrew J. Vickers,et al.  A simple, step-by-step guide to interpreting decision curve analysis , 2019, Diagnostic and Prognostic Research.

[10]  Gerta Rücker,et al.  How to perform a meta-analysis with R: a practical tutorial , 2019, Evidence-Based Mental Health.

[11]  C. Jackson,et al.  Effectiveness of BCG vaccination against Mycobacterium tuberculosis infection in adults: a cross-sectional analysis of a UK-based cohort. , 2019, The Journal of infectious diseases.

[12]  Carolin T. Turner,et al.  Concise whole blood transcriptional signatures for incipient tuberculosis: a systematic review and patient-level pooled meta-analysis , 2019, bioRxiv.

[13]  B. Chain,et al.  Blood transcriptomic stratification of short-term risk in contacts of tuberculosis. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  J. Deeks,et al.  Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study , 2019 .

[15]  M. Behr,et al.  Revisiting the timetable of tuberculosis , 2018, British Medical Journal.

[16]  D. Sherman,et al.  Incipient and Subclinical Tuberculosis: a Clinical Review of Early Stages and Progression of Infection , 2018, Clinical Microbiology Reviews.

[17]  Cyril Ferdynus,et al.  Decision curve analysis: a technical note. , 2018, Annals of translational medicine.

[18]  S. Self,et al.  Prevention of Infection with Mycobacterium tuberculosis by H4:IC31® Vaccination or BCG Revaccination in Adolescents , 2018, The New England journal of medicine.

[19]  Karel G M Moons,et al.  Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model , 2018, The Lancet Neurology.

[20]  Richard A. White,et al.  Stratification by interferon-γ release assay level predicts risk of incident TB , 2018, Thorax.

[21]  Jiawei Li,et al.  Myeloid-derived suppressor cells in transplantation: the dawn of cell therapy , 2018, Journal of Translational Medicine.

[22]  Richard D Riley,et al.  Meta-analysis of prediction model performance across multiple studies: Which scale helps ensure between-study normality for the C-statistic and calibration measures? , 2017, Statistical methods in medical research.

[23]  L. Moulton,et al.  A score to predict and stratify risk of tuberculosis in adult contacts of tuberculosis index cases: a prospective derivation and external validation cohort study , 2017, The Lancet. Infectious diseases.

[24]  Ross J. Harris,et al.  Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysis. , 2017, Annals of internal medicine.

[25]  Ross J. Harris,et al.  Evaluating 17 years of latent tuberculosis infection screening in north-west England: a retrospective cohort study of reactivation , 2017, European Respiratory Journal.

[26]  J. Andrews,et al.  Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study. , 2017, The Lancet. Respiratory medicine.

[27]  V. Cook,et al.  Impact of interferon-γ release assay on the latent tuberculosis cascade of care: a population-based study , 2017, European Respiratory Journal.

[28]  Vincent Audigier,et al.  Multiple Imputation for Multilevel Data with Continuous and Binary Variables , 2017, 1702.00971.

[29]  H. Alsdurf,et al.  The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis. , 2016, The Lancet. Infectious diseases.

[30]  F. Cobelens,et al.  Risk of developing tuberculosis disease among persons diagnosed with latent tuberculosis infection in the Netherlands , 2016, European Respiratory Journal.

[31]  Richard D Riley,et al.  Explicit inclusion of treatment in prognostic modeling was recommended in observational and randomized settings. , 2016, Journal of clinical epidemiology.

[32]  B. Kampmann,et al.  The impact of BCG vaccination on tuberculin skin test responses in children is age dependent: evidence to be considered when screening children for tuberculosis infection , 2016, Thorax.

[33]  Frank E. Harrell,et al.  Prediction models need appropriate internal, internal-external, and external validation. , 2016, Journal of clinical epidemiology.

[34]  V. Cook,et al.  Knowledge and Perceptions of Latent Tuberculosis Infection among Chinese Immigrants in a Canadian Urban Centre , 2015, International journal of family medicine.

[35]  Ross J. Harris,et al.  Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries , 2015, European Respiratory Journal.

[36]  Johannes B. Reitsma,et al.  Individual Participant Data (IPD) Meta-analyses of Diagnostic and Prognostic Modeling Studies: Guidance on Their Use , 2015, PLoS medicine.

[37]  T. Yoshiyama,et al.  Use of the QuantiFERON®-TB Gold in Tube test for screening TB contacts and predictive value for active TB , 2015, Infectious diseases.

[38]  R. Chaisson,et al.  Latent Mycobacterium tuberculosis infection. , 2015, The New England journal of medicine.

[39]  R. Duarte,et al.  Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study. , 2015, American journal of respiratory and critical care medicine.

[40]  A. Orcau,et al.  Predicting the Development of Tuberculosis with the Tuberculin Skin Test and QuantiFERON Testing. , 2015, Annals of the American Thoracic Society.

[41]  Richard D Riley,et al.  Preferred Reporting Items for a Systematic Review and Meta-analysis of Individual Participant Data: The PRISMA-IPD Statement , 2015 .

[42]  J. Castellote,et al.  Immunodiagnostic Tests’ Predictive Values for Progression to Tuberculosis in Transplant Recipients: A Prospective Cohort Study , 2015, Transplantation direct.

[43]  I. Abubakar,et al.  Treatment of Latent Tuberculosis Infection , 2015, Annals of Internal Medicine.

[44]  G. Collins,et al.  Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement , 2015, BMJ : British Medical Journal.

[45]  F. van Leth,et al.  Risk assessment of tuberculosis in immunocompromised patients. A TBNET study. , 2014, American journal of respiratory and critical care medicine.

[46]  P. Kouw,et al.  Risk of tuberculosis after recent exposure. A 10-year follow-up study of contacts in Amsterdam. , 2014, American journal of respiratory and critical care medicine.

[47]  Yvonne Vergouwe,et al.  Towards better clinical prediction models: seven steps for development and an ABCD for validation. , 2014, European heart journal.

[48]  J. Denholm,et al.  Latent Tuberculosis Screening Using Interferon-Gamma Release Assays in an Australian HIV-Infected Cohort: Is Routine Testing Worthwhile? , 2014, Journal of acquired immune deficiency syndromes.

[49]  M. Pai,et al.  Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection , 2014, Clinical Microbiology Reviews.

[50]  A. Hauri,et al.  How can we achieve better prevention of progression to tuberculosis among contacts? , 2013, European Respiratory Journal.

[51]  G. Marks,et al.  Risk of tuberculosis among contacts in a low-incidence setting , 2012, European Respiratory Journal.

[52]  E. W. Hoskyns,et al.  Single-step QuantiFERON screening of adult contacts: a prospective cohort study of tuberculosis risk , 2012, Thorax.

[53]  W. Kern,et al.  Development of tuberculosis in immunocompromised patients with a positive tuberculosis-specific IGRA. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[54]  M. Pai,et al.  Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis. , 2012, The Lancet. Infectious diseases.

[55]  Patrick Royston,et al.  Multiple imputation using chained equations: Issues and guidance for practice , 2011, Statistics in medicine.

[56]  Jörg Drechsler,et al.  Multiple Imputation for Nonresponse , 2011 .

[57]  S. Niemann,et al.  Negative and positive predictive value of a whole-blood interferon-γ release assay for developing active tuberculosis: an update. , 2011, American journal of respiratory and critical care medicine.

[58]  F. Cobelens,et al.  LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement , 2009, European Respiratory Journal.

[59]  A. Rieger,et al.  Detection and prediction of active tuberculosis disease by a whole-blood interferon-gamma release assay in HIV-1-infected individuals. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[60]  M. Pai,et al.  Thinking in three dimensions: a web-based algorithm to aid the interpretation of tuberculin skin test results. , 2008, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[61]  S. Egwaga,et al.  Tuberculin skin testing in patients with HIV infection: limited benefit of reduced cutoff values. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[62]  P. Royston,et al.  Flexible parametric proportional‐hazards and proportional‐odds models for censored survival data, with application to prognostic modelling and estimation of treatment effects , 2002, Statistics in medicine.